- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05734144
Two Institutes Experience in Laparo-Endoscopic Rendezvous Technique for Gallbladder and Bile Duct Stones
February 14, 2023 updated by: Mohamed I Farid, Zagazig University
Two Institutes Experience In Laparo-Endoscopic Rendezvous Technique For Patients Undergoing Laparscopic Cholecystectomy For Stones In The Gallbladder And Bile Duct; A Prospective Randomized Comparative Clinical Trial
The management of gallbladder stones (lithiasis) concomitant with bile duct stones is controversial.
The management of CBD stones has evolved considerably since the advent of laparoscopic surgery.
The more frequent approach is a two-stage procedure, with endoscopic sphincterotomy and stone removal from the bile duct followed by laparoscopic cholecystectomy.
The laparoscopic-endoscopic rendezvous combines the two techniques in a single-stage operation.
So the aim of this study was was to evaluate one-stage LC with intra-operative endoscopic sphincterotomy (IOES) vs two-stage pre-operative endoscopic sphincterotomy (POES) followed by LC for the treatment of cholecystocholedocholithiasis.
Study Overview
Status
Completed
Conditions
Detailed Description
This is two center study was carried out on 523 patients and completed in 436 patients with gall bladder stones and with suspected or confirmed CBDS at two gastroenterology center at zagazig first 264 patients at the Gastrointestinal Surgery Unit in the Zagazig University Hospitals and second 172 patients at gastroenterology unite at AL AHRAR hospital from January 2010 till April 2022.
A single-step technique combining LC and IO-ERCP was used to treat them.
To confirm the presence of CBDS, a laparoscopic intraoperative cholangiography (IOC) was performed.
A soft-tipped guidewire was inserted into the duodenum through the cystic duct and papilla.
Over the guide-wire, an endoscopic papillotomy was introduced.
The stones were retrieved with a retrieval balloon after an IO-ERCP and endoscopic sphincterotomy.
The length of the postoperative hospital stay, surgical operating time, surgical success rate, postoperative complications, and residual CBDS were all evaluated.
77 patients excluded either incomplete data or didn't complete both steps within our centers.
Study Type
Interventional
Enrollment (Actual)
432
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients having stone in the gallbladder and concurrent CBD stone, as determined by MRCP or US.
- Patients with acute cholecystitis, acute cholangitis, obstructive jaundice, and those with highly suspicious criteria for CBD, stones such as dilated CBD on US examination more than7 mm in diameter without obvious CBD stones, high serum bilirubin level, and or high serum alkaline phosphatase level, were also included in this study.
Exclusion Criteria:
- Patients with history of hepatobiliary surgery as choledocho-duodenal anastomosis.
- Patients with previous ERCP attempt.
- Patients with previous upper abdominal surgery as total or partial gastric resection.
- Patients with morbid obesity.
- Patients with uncorrectable coagulopathy.
- Patients aged below 18 years or above 80 years.
- Patients within the American Society of Anesthesiology (ASA) class 4 and 5 disease.
- Patients who refused to give consent or participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Laparo-endoscopic "rendezvous" technique
the first group was treated by a single-step procedure combining LC and IOES
|
combination approach has been used to improve patient compliance and shorten hospital stays.
The intraoperative ERCP has been performed immediately before Laparoscopic Cholecystectomy
|
|
Other: POES followed by LC
the second (control) group was treated by 2-stage (sequential treatment) POES followed by LC.
|
Treatment in two stages, which combines a preoperative ES followed by LC (sequential treatment).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
successful stone clearance from the CBD
Time Frame: first year postoperatively
|
To ensure that the bile duct was completely clear, a check cholangiogram was conducted.
|
first year postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2010
Primary Completion (Actual)
April 1, 2022
Study Completion (Actual)
December 1, 2022
Study Registration Dates
First Submitted
February 3, 2023
First Submitted That Met QC Criteria
February 14, 2023
First Posted (Actual)
February 17, 2023
Study Record Updates
Last Update Posted (Actual)
February 17, 2023
Last Update Submitted That Met QC Criteria
February 14, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10129/20-11-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Calculus; Gallbladder, With Cholecystitis
-
University of Witten/HerdeckeCompletedLaparoscopic Cholecystectomy | Calculus of Gallbladder With or Without CholecystitisGermany
-
Hospital General de Chihuahua - Dr. Salvador Zubirán...CompletedAcute Cholecystitis | Acute Cholecystitis With ObstructionMexico
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHigh-risk Patients With Acute Calculous Cholecystitis (ACC)Italy
-
Aswan UniversityCompletedAcute Calculous Cholecystitis | Gallbladder Empyema | Gallbladder MucoceleEgypt
-
Samsun Education and Research HospitalCompletedAcute Cholecystitis With Chronic CholecystitisTurkey
-
Lumbini Medical CollegeCompletedCholedocholithiasis With Cholecystitis With Obstruction | Choledocholithiasis With Acute and Chronic Cholecystitis | Cholelithiasis With Acute and Chronic Cholecystitis
-
University of LorraineCompletedCholecystitis, Acute | Child, Only | Cholecystitis, Chronic | Gall Stones (& [Calculus - Gall Bladder]) | Pancreatitis Due to GallstonesFrance
-
Region ÖstergötlandCompletedGall Stone | Gallbladder | Gallbladder Inflammation | Gall Stones (&Amp; [Calculus - Gall Bladder])
-
Services Hospital, LahoreServices Institute of Medical Sciences, PakistanCompletedCholecystitis | Cholecystectomy, Laparoscopic | Gall Stones (& [Calculus - Gall Bladder])Pakistan
-
Konya Meram State HospitalUnknownCholecystitis; Acute, With CholelithiasisTurkey
Clinical Trials on The intraoperative ERCP has been performed immediately before LC
-
University of BaghdadCompletedOccupational Toxicity and Health Hazards of the Healthcare Providers at Healthcare Facilities in Sulaimani City, IraqIraq
-
University of MagdeburgEBS Technologies GmbHCompletedVisual ImpairmentGermany